|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.23 USD | -1.62% |
|
-4.86% | -23.91% |
| 16/05 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 12/05 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
| Market Cap | 114.26Cr 100Cr 92Cr 85Cr 161.56Cr 11TCr 164.28Cr 1.1TCr 432.56Cr 5.37TCr 429.03Cr 419.69Cr 18TCr | P/E 2026 * |
13.2x | P/E 2027 * | 9.45x |
|---|---|---|---|---|---|
| Enterprise Value | 189.35Cr 165.62Cr 152.77Cr 141.1Cr 267.72Cr 18TCr 272.23Cr 1.83TCr 716.8Cr 8.9TCr 710.95Cr 695.48Cr 31TCr | EV / Sales 2026 * |
2.17x | EV / Sales 2027 * | 1.66x |
| Free-Float |
77.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Collegium Pharmaceutical, Inc.
| 1 day | -1.62% | ||
| 1 week | -4.86% | ||
| Current month | -2.68% | ||
| 1 month | +1.70% | ||
| 3 months | -0.68% | ||
| 6 months | -26.83% | ||
| Current year | -23.91% |
| 1 week | 34.57 |  | 38.5 |
| 1 month | 31.69 | | 38.5 |
| Current year | 30.13 | | 49.31 |
| 1 year | 29.19 | | 50.79 |
| 3 years | 20.95 | | 50.79 |
| 5 years | 14.04 | | 50.79 |
| 10 years | 7.37 | | 50.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikram Karnani
CEO | Chief Executive Officer | 51 | 12/11/2024 |
Colleen Tupper
DFI | Director of Finance/CFO | 50 | 24/05/2021 |
Scott Sudduth
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 78 | 01/01/2015 |
Gino Santini
CHM | Chairman | 69 | 15/05/2025 |
John Freund
BRD | Director/Board Member | 72 | 01/02/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/06 | Fiscal year | Chairman | 17,400 | 0.0536% | ||
| 18/05 | Sell | Director | -20 | 0.0001% | ||
| 15/05 | Fiscal year | Director | 21,527 | 0.0664% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.62% | -4.86% | +8.33% | +63.40% | 114.26Cr | |
| -2.33% | -2.09% | +49.88% | +169.76% | 1,06000Cr | |
| -0.82% | -2.30% | +63.79% | +62.56% | 62TCr | |
| -0.73% | -4.98% | +28.91% | +83.79% | 44TCr | |
| -0.39% | +1.24% | +30.35% | +25.52% | 33TCr | |
| -0.33% | -0.80% | +28.69% | +46.69% | 28TCr | |
| -1.24% | -9.63% | +19.51% | +23.35% | 27TCr | |
| +0.47% | +0.65% | -27.08% | -38.19% | 22TCr | |
| -0.06% | -2.88% | +23.07% | +61.02% | 20TCr | |
| -3.72% | -1.10% | +18.41% | +69.98% | 16TCr | |
| Average | -1.07% | -3.49% | +24.39% | +56.79% | 35.75TCr | |
| Weighted average by Cap. | -1.21% | -3.10% | +36.36% | +83.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 87Cr 76Cr 71Cr 65Cr 123.66Cr 8.34TCr 125.74Cr 843.08Cr 331.08Cr 4.11TCr 328.38Cr 321.23Cr 14TCr | 89Cr 77Cr 71Cr 66Cr 125.25Cr 8.45TCr 127.36Cr 853.95Cr 335.35Cr 4.16TCr 332.61Cr 325.38Cr 14TCr |
| Net income | 11Cr 9.47Cr 8.73Cr 8.06Cr 15Cr 1.03TCr 16Cr 104.33Cr 41Cr 508.48Cr 41Cr 40Cr 1.75TCr | 16Cr 14Cr 13Cr 12Cr 22Cr 1.51TCr 23Cr 152.6Cr 60Cr 743.77Cr 59Cr 58Cr 2.56TCr |
| Net Debt | 75Cr 66Cr 61Cr 56Cr 106.16Cr 7.16TCr 107.95Cr 723.81Cr 284.24Cr 3.53TCr 281.92Cr 275.79Cr 12TCr | 33Cr 29Cr 26Cr 24Cr 46Cr 3.13TCr 47Cr 315.89Cr 124.05Cr 1.54TCr 123.04Cr 120.36Cr 5.29TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | $35.23 | -1.62% | 2,86,216 |
| 09/26/09 | $35.81 | -0.06% | 4,66,329 |
| 08/26/08 | $35.83 | -1.67% | 4,45,359 |
| 07/26/07 | $36.44 | -2.75% | 4,71,253 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLL Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
